GURU.Markets stock price, segment price, and overall market index valuation
The company's share price IM Cannabis Corp.
IM Cannabis is a Canadian company selling medical cannabis in Israel and Germany. Its stock price reflects the ups and downs of the industry. The chart tells the story of regulatory changes, competition, and the difficult path to profitability.
Share prices of companies in the market segment - Narco farm
IM Cannabis is an Israeli company that cultivates, produces, and distributes medical cannabis in Israel and Germany. We've classified it as a "Drug Farm." The chart below reflects the high volatility and regulatory risks of this growing market.
Broad Market Index - GURU.Markets
IM Cannabis is an Israeli company that produces and sells medical cannabis in Israel and Germany. Its international reach makes it a prominent player in the GURU.Markets index. The chart below shows the entire market. Find out how IMC compares to it.
Change in the price of a company, segment, and market as a whole per day
IMCC - Daily change in the company's share price IM Cannabis Corp.
The daily price change of IM Cannabis Corp. reflects the high volatility of the cannabis industry. The indicator demonstrates sensitivity to regulatory changes in Germany and Israel, as well as product prices.
Daily change in the price of a set of shares in a market segment - Narco farm
IM Cannabis is a cannabis company known for its high volatility due to regulatory changes and market competition. The chart below shows the average daily turbulence in this sector. This provides a benchmark for assessing how typical IMCC stock is for its industry.
Daily change in the price of a broad market stock, index - GURU.Markets
IM Cannabis is an Israeli company that grows and sells medical cannabis. Its shares reflect both the industry's rapid growth and regulatory risks. The sector's dynamics add a unique and volatile element to the overall market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization IM Cannabis Corp.
IM Cannabis Corp.'s year-over-year performance tells the story of its performance in the international cannabis market. Its market cap change over the past 12 months reflects its success in its key marketsโIsrael and Germany. Its valuation is a bet on the success of its strategy to build a global brand and distribution network.
Annual dynamics of market capitalization of the market segment - Narco farm
IM Cannabis Corp. is an Israeli cannabis company with operations in several countries. Its performance is heavily dependent on progress in legalization and its ability to achieve profitability. The chart below shows how these factors, along with intense competition, influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
IM Cannabis, which operates in the Israeli and German markets, reflects the specifics of legalization in these countries with its dynamics. Its results, compared to global markets, are not about economics, but about local laws, taxes, and the competitive environment. It's a local story in a global industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization IM Cannabis Corp.
IM Cannabis is a diversified cannabis company with operations in several countries. Its monthly performance reflects both consumer trends and complex regulatory changes in the markets where it operates (such as Germany and Israel).
Monthly dynamics of market capitalization of the market segment - Narco farm
IM Cannabis Corp. is an international medical cannabis company with operations in Israel and Germany. Its sector dynamics, shown in the chart, are volatile and dependent on regulatory changes. Against this backdrop, one can appreciate how its strategy, focused on highly regulated medical markets, differentiates it from other players in the industry.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
IM Cannabis is an Israeli cannabis company operating in the Israeli and German markets. Its stock price moves based on news of legalization and sales in these regions. The chart shows the dynamics, which are determined entirely by the specifics of the cannabis industry, rather than general market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization IM Cannabis Corp.
IM Cannabis is an Israeli company operating in the medical cannabis market in Israel and Germany. Its weekly stock price reflects legislative changes, competition, and its operational performance in these markets.
Weekly dynamics of market capitalization of the market segment - Narco farm
IM Cannabis Corp. operates in the cannabis market, which is highly dependent on regulatory changes. The chart clearly demonstrates how closely the company's weekly stock price movements are tied to legalization news and how they compare to the sector-wide average.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
IM Cannabis Corp., operating in the cannabis market, is heavily dependent on regulatory changes. The chart clearly demonstrates how closely the company's weekly stock price fluctuations are tied to legalization news rather than to overall economic trends.
Market capitalization of the company, segment and market as a whole
IMCC - Market capitalization of the company IM Cannabis Corp.
The chart for IM Cannabis Corp. reflects the complexities of the international cannabis market. The market cap of this company, with operations in Israel, Germany, and Canada, reflects how investors assess its ability to navigate diverse regulatory environments and achieve profitability.
IMCC - Share of the company's market capitalization IM Cannabis Corp. within the market segment - Narco farm
IM Cannabis is an Israeli company engaged in the production and distribution of medical cannabis in Israel, Germany, and Canada. Within the legal cannabis sector, its market capitalization reflects its international presence. The company's market capitalization is an indicator of its ability to navigate the complex and varied regulations in its key markets.
Market capitalization of the market segment - Narco farm
IM Cannabis is an Israeli company operating in the international cannabis market. How big is this emerging industry? The chart below shows the pulse of this speculative sector. Its rollercoaster ride reflects the challenging path to legalization and building a global business in this industry.
Market capitalization of all companies included in a broad market index - GURU.Markets
The IM Cannabis chart shows how the market values โโan international cannabis player with operations in Israel, Germany, and Canada. Its market capitalization reflects all the complexities of the sector: from regulatory barriers to intense competition and profitability issues. This is a diagram of global ambitions and local challenges.
Book value capitalization of the company, segment and market as a whole
IMCC - Book value capitalization of the company IM Cannabis Corp.
The book value of Israeli IM Cannabis is derived from its tangible assets: greenhouses and production facilities for growing and processing medical cannabis in Israel and Germany. The chart below shows how the value of this international production base has changed.
IMCC - Share of the company's book capitalization IM Cannabis Corp. within the market segment - Narco farm
IM Cannabis Corp. is an international company in the cannabis industry. Its assets include greenhouses and production facilities in Israel and Germany, as well as a network of dispensaries. The chart shows the share of this international infrastructure, from cultivation to distribution, that the company controls.
Market segment balance sheet capitalization - Narco farm
IM Cannabis is a cannabis producer and distributor. This sector, as the chart shows, is capital-intensive. IM Cannabis' business includes greenhouses, processing plants, and dispensaries in various countries.
Book value of all companies included in the broad market index - GURU.Markets
IM Cannabis' assets are not plantations, but rather an international company engaged in the distribution and sale of medical cannabis in Israel and Germany. Its book value reflects its logistics and retail infrastructure in these highly regulated markets.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - IM Cannabis Corp.
IM Cannabis is a cannabis company operating in Israel and Germany. Its market capitalization reflects its position in these markets. The chart shows how investors view regulatory changes and competition in the global cannabis industry.
Market to book capitalization ratio in a market segment - Narco farm
IM Cannabis is an international company operating in the medical cannabis industry. Its valuation depends on regulatory changes and its ability to build brands and distribution across multiple markets. The chart shows how investors view its global strategy.
Market to book capitalization ratio for the market as a whole
IM Cannabis is a company operating in the cannabis market. Its valuation depends on its brands, cultivation licenses, and distribution network. This chart helps understand how investors value companies in this new, fast-growing, yet still risky industry compared to more established sectors.
Debts of the company, segment and market as a whole
IMCC - Company debts IM Cannabis Corp.
IM Cannabis is a company operating in the medical and recreational cannabis markets in several countries. This sector requires capital for cultivation, processing, distribution, and compliance with complex regulatory requirements. This chart illustrates how the company is using debt to finance its international expansion and brand building.
Market segment debts - Narco farm
IM Cannabis is a company operating in the cannabis industry across several countries. The sector remains challenging due to regulatory barriers and intense competition. This chart shows the company's financial health and how it is managing its debt in this challenging environment.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio IM Cannabis Corp.
IM Cannabis Corp. is a company operating in the cannabis industry. This chart shows its debt load. In a volatile market with changing regulations and intense competition, high debt levels are extremely risky. They could lead to insolvency if prices fall or market share is lost.
Market segment debt to market segment book capitalization - Narco farm
IM Cannabis is an Israeli company operating in the international medical cannabis market. This sector faces various regulatory regimes and is highly competitive. This chart shows the overall debt burden in the industry, which helps assess how the company manages its finances and risks when doing business in different countries.
Debt to book value of all companies in the market
IM Cannabis Corp. is an Israeli company operating in the international cannabis market. The sector still faces regulatory challenges and limited access to traditional bank financing. This chart contrasts general lending conditions with the challenging reality for cannabis companies.
P/E of the company, segment and market as a whole
P/E - IM Cannabis Corp.
This metric for IM Cannabis, a company operating in the cannabis market, reflects the complexities of the industry. The P/E (if positive) will be volatile. It reflects the struggle for profitability in an environment of intense competition, oversupply, and complex regulations in various countries.
P/E of the market segment - Narco farm
IM Cannabis is a multinational company engaged in the production, distribution, and sale of medical and recreational cannabis, with operations in Israel, Germany, and Canada. This chart shows the average valuation for the sector, helping to understand how the market values โโthis international player in the cannabis industry.
P/E of the market as a whole
IM Cannabis is an Israeli company operating in the medical cannabis industry with operations in Israel and Germany. Its valuation is determined not by the economic cycles reflected in this chart, but by industry-specific factors: the pace of legalization in Europe, price competition, and the company's ability to build distribution.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company IM Cannabis Corp.
IM Cannabis is an international medical cannabis company with operations in Israel and Germany. This chart reflects expected growth in the legal cannabis markets in these countries. Future profitability depends on regulatory policies, demand for medical cannabis, and the effectiveness of its operations.
Future (projected) P/E of the market segment - Narco farm
IM Cannabis is an Israeli company producing and selling medical cannabis in Israel and Germany. Its valuation relative to other cannabis companies reflects investor opinions on its position in these key markets. This reflects how the market assesses its ability to navigate the complex regulatory environment and grow sales.
Future (projected) P/E of the market as a whole
IM Cannabis is an Israeli company engaged in the production and sale of medical cannabis in Israel and Germany. Its business is dependent on the regulatory environment and growing demand for medical marijuana. This chart reflects overall investor sentiment towards the cannabis sector, which is volatile and highly dependent on legislative changes in various countries.
Profit of the company, segment and market as a whole
Company profit IM Cannabis Corp.
IM Cannabis Corp. is an international company engaged in the production and sale of medical cannabis with operations in Israel and Germany. Its financial results, illustrated by this chart, depend on the regulatory environment, cannabis prices, and its ability to grow sales in these markets.
Profit of companies in the market segment - Narco farm
IM Cannabis Corp. cultivates, produces, and sells medical cannabis. This chart shows the overall profitability of the cannabis sector. It illustrates the challenges the entire industry faces in achieving sustainable profitability, including legalization, taxation, and competition from the black market.
Overall market profit
IM Cannabis is a company engaged in the cultivation, production, and sale of medical cannabis in Israel and Germany. Its success depends on regulation, competition, and the ability to grow its market share in these markets. This industry-specific growth is more important to IMCC than the general economic cycles depicted in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company IM Cannabis Corp.
IM Cannabis is a company engaged in the cultivation, production, and sale of medical cannabis. Its future profits depend on the legalization and growth of the cannabis market in countries where it operates, such as Israel and Germany. This chart reflects analyst expectations for the development of this industry.
Future (predicted) profit of companies in the market segment - Narco farm
IM Cannabis Corp. is an international company engaged in the production and sale of medical cannabis, with operations in Israel and Germany. The company's business is dependent on the regulatory environment and the development of legal markets. This chart shows forecasts for the cannabis sector. It helps assess how companies are adapting to changing regulations and the highly competitive nature of this young industry.
Future (predicted) profit of the market as a whole
This chart shows legislative trends and consumer spending in the cannabis sector. For IM Cannabis Corp., this defines market opportunities. Economic growth and legalization are driving market expansion. Legislative uncertainty and an economic downturn could negatively impact demand.
P/S of the company, segment and market as a whole
P/S - IM Cannabis Corp.
IM Cannabis is a company selling medical cannabis in Israel and Germany. This chart shows how investors view its revenue in these legalized, yet still developing and competitive, markets.
P/S market segment - Narco farm
IM Cannabis Corp. is an international company engaged in the cultivation, production, and sale of medical and recreational cannabis in Israel, Canada, and Germany. This chart shows the average valuation in the cannabis sector. It helps understand how investors view IMC's international strategy and its position in various regulated markets.
P/S of the market as a whole
IM Cannabis Corp. is an international company engaged in the production and sale of medical cannabis with operations in Israel and Germany. The company's revenue depends on the growth of legal cannabis markets and the regulatory environment. This chart provides an overview of market sentiment for this emerging, yet still complex, industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company IM Cannabis Corp.
IM Cannabis Corp. is an international medical cannabis production and sales company with operations in Israel, Germany, and Canada. Future revenue depends on the regulatory environment and growth of these markets. The chart shows how investors view its international strategy and prospects in the global cannabis market.
Future (projected) P/S of the market segment - Narco farm
IM Cannabis Corp. is an international company engaged in the cultivation, production, and sale of medical and recreational cannabis. It has operations in Israel, Germany, and Canada. This chart shows how the market estimates its future sales in the complex and fragmented global cannabis market.
Future (projected) P/S of the market as a whole
This reflects investors' faith in the cannabis market. For IM Cannabis, an international company operating in Israel and Germany, this is an indicator of legalization and market growth. Optimism in this sector stems from the gradual lifting of restrictions and growing demand for medical and recreational cannabis.
Sales of the company, segment and market as a whole
Company sales IM Cannabis Corp.
IM Cannabis is one of the leading companies in the medical cannabis market in Israel and Germany. This chart shows revenue from cultivation, production, and sales of cannabis products. Its dynamics depend on the regulatory environment, consumer demand, and the company's ability to maintain market share in competitive markets.
Sales of companies in the market segment - Narco farm
IM Cannabis Corp. is an international company engaged in the cultivation, production, and sale of medical and recreational cannabis. This chart reflects the dynamics of the cannabis sector. IM Cannabis operates in several markets, including Israel and Germany, and its development is part of the global process of legalization and growth of this emerging industry.
Overall market sales
IM Cannabis Corp. produces and sells medical cannabis in Israel and Germany. Demand for its products depends on legislation and the development of the medical market. The overall economic situation, shown in this chart, influences consumer spending and the pace of legalization, which drive the industry.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company IM Cannabis Corp.
IM Cannabis Corp. is an Israeli company engaged in the production and sale of medical cannabis in Israel and Germany. Its growth depends on the development of legal cannabis markets in these countries. This chart shows analysts' forecasts for the growth of the European cannabis market and the company's position within it.
Future (projected) sales of companies in the market segment - Narco farm
IM Cannabis Corp. cultivates, produces, and sells medical cannabis. This chart outlines expectations for the entire cannabis industry. It reflects regulatory changes and evolving public attitudes, which are key factors driving the growth of this emerging market.
Future (projected) sales of the market as a whole
IM Cannabis Corp. is an international medical cannabis company with operations in Israel and Germany. Its success depends on the regulatory environment and growing demand for medical cannabis. This graph, reflecting overall consumer trends, influences demand for health and wellness products, including the company's products, in legal markets.
Marginality of the company, segment and market as a whole
Company marginality IM Cannabis Corp.
IM Cannabis is a Canadian company operating in the international medical cannabis market, particularly in Israel and Germany. This chart shows profitability in a highly regulated and competitive industry. Profitability depends on sales volume, pricing, and the ability to navigate complex legislation in different countries.
Market segment marginality - Narco farm
IM Cannabis Corp. produces and sells medical and recreational cannabis in Israel, Germany, and Canada. Profitability in this industry depends on regulatory frameworks, yields, and brand strength. This chart shows the average profitability in the sector, helping to assess how effectively IM Cannabis operates in its key markets.
Market marginality as a whole
IM Cannabis is a Canadian company engaged in the production and sale of medical and recreational cannabis in international markets. This overall market profitability graph is less important than regulatory changes and the growth of legal cannabis markets. Legalization and consumer demand determine the company's growth potential and profitability.
Employees in the company, segment and market as a whole
Number of employees in the company IM Cannabis Corp.
IM Cannabis is an international company engaged in the production and sale of medical cannabis with operations in Israel, Germany, and Canada. The chart shows the team involved in cultivation, processing, and distribution. The dynamics of the team reflect regulatory changes and competition in different markets.
Share of the company's employees IM Cannabis Corp. within the market segment - Narco farm
IM Cannabis Corp. is an international company engaged in the production and distribution of medical cannabis. This chart shows its importance as an employer in this increasingly legal industry. It reflects the share of agronomists, technologists, regulatory and distribution specialists in the cannabis industry the company attracts in its markets of Israel, Germany, and Canada.
Number of employees in the market segment - Narco farm
IM Cannabis Corp. is an Israeli company operating in the international medical cannabis market. This chart illustrates how legalization is creating a new global industry that requires specialists in a wide range of fields: from agronomists cultivating raw materials to pharmacists developing medicinal products and lawyers navigating complex regulations.
Number of employees in the market as a whole
IM Cannabis Corp. is a company operating in the cannabis market, a new and rapidly growing industry. Legalization is creating an entirely new industry with jobs in agronomy, processing, retail, and logistics. This graph is gradually beginning to reflect this new sector, which simply didn't exist in the legal space just a few years ago.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company IM Cannabis Corp. (IMCC)
IM Cannabis Corp. is an international company operating in the medical cannabis industry. This chart reflects both capital intensity (greenhouses, processing facilities) and intellectual capital (brands, distribution licenses). It shows the combined market valuation of these assets in this growing industry per employee.
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
IM Cannabis Corp. produces and sells medical cannabis. In this young and growing industry, branding, product quality, and regulatory compliance are crucial. The chart shows how the market views their business model and ability to capture market share.
Market capitalization per employee (in thousands of dollars) for the overall market
IM Cannabis Corp. is an international company operating in the medical cannabis sector. This chart shows the market average per-employee value, which helps evaluate the company in this emerging and regulated industry.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company IM Cannabis Corp. (IMCC)
IM Cannabis is a company operating in the cannabis market. This business encompasses cultivation, processing, and retail sales. This chart demonstrates how efficient this entire vertically integrated chain is. It reflects how much net profit each employee, from agronomist to store clerk, generates.
Profit per employee (in thousands of dollars) in the market segment - Narco farm
IM Cannabis Corp. cultivates, produces, and sells medical cannabis in Israel and Germany. Success in this industry depends on yield, product quality, and the ability to navigate a complex regulatory environment. This chart shows the profit each employee, from agronomist to sales manager, generates in this fast-growing but complex market.
Profit per employee (in thousands of dollars) for the market as a whole
IM Cannabis (IMCC) is an Israeli company that grows, produces, and sells medical cannabis in Israel and Germany. This agri-pharma business requires R&D and production facilities (greenhouses). This chart shows the average profit per employee (for the US). It helps investors understand how IMCC (cannabis in Europe/Israel) compares in labor efficiency to the US market average.
Sales to employees of the company, segment and market as a whole
Sales per company employee IM Cannabis Corp. (IMCC)
IM Cannabis is a company engaged in the production and sale of medical cannabis in Israel and Germany. This chart reflects the dynamics of the regulated cannabis industry, demonstrating how successfully the company manages its production and distribution to meet patient demand.
Sales per employee in the market segment - Narco farm
IM Cannabis Corp. (IMCC) is an international medical cannabis company with operations in Israel and Germany. This chart shows the average revenue per employee in the segment. It helps assess how effectively IMCC (cultivation and distribution) performs in the complex, regulated cannabis markets compared to its competitors.
Sales per employee for the market as a whole
IM Cannabis Corp. is an Israeli company operating in the international medical cannabis market (Israel, Germany). This chart shows how effectively their team (agronomists, logistics, sales) generates revenue in a complex and highly regulated market.
Short shares by company, segment and market as a whole
Shares shorted by company IM Cannabis Corp. (IMCC)
IM Cannabis is an Israeli company attempting to establish a cannabis business in Israel and Germany. The sector is known for its fierce competition and regulatory barriers. This chart shows the bets that the company will burn through all its cash. The bears believe the market is oversaturated and product prices are falling, making the business unprofitable.
Shares shorted by market segment - Narco farm
IM Cannabis Corp. (IMCC) is an international cannabis company operating in the Israeli and German markets, cultivating and distributing medical cannabis. This chart reflects the overall short position in the cannabis sector. High values โโhere indicate investors are skeptical of the industry's profitability due to strict regulation and price competition.
Shares shorted by the overall market
IM Cannabis is an international company operating in the complex and regulated cannabis markets of Israel and Germany. This chart measures overall fear. The cannabis sector is already suffering from a capital shortage. When general market pessimism is added to this, investors completely lose their risk appetite, selling off IMCC shares, fearing their inability to achieve profitability.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator IM Cannabis Corp. (IMCC)
IM Cannabis Corp. is an international cannabis production and sales company with operations in Canada, Germany, and Israel. The sector is known for its volatility. This indicator tracks the hype around legalization (above 70) and periods of deep disappointment (below 30), when market growth fails to meet expectations.
RSI 14 Market Segment - Narco farm
IM Cannabis Corp. is an international medical cannabis company with operations in Israel, Germany, and Canada. This chart measures the collective excitement or decline across the entire cannabis sector. It helps understand whether the entire segment is oversold due to regulatory delays and intense competition.
RSI 14 for the overall market
IM Cannabis, a cannabis producer, sees risk appetite in this chart. During periods of euphoria, investors are willing to invest in "growth stories," ignoring losses and regulatory risks. In moments of panic, capital flees speculative, unprofitable industries, and the cash spigot for cannabis companies is shut off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IMCC (IM Cannabis Corp.)
IM Cannabis is an international cannabis production and distribution company with a strong presence in Israel and Germany. This chart shows the average analyst forecast. Their targets are based on sales growth in these markets, expected regulatory changes (legalization in Germany), and the company's path to operational profitability.
The difference between the consensus estimate and the actual stock price IMCC (IM Cannabis Corp.)
IM Cannabis is an Israeli company that owns a network of pharmacies and medical cannabis logistics in Israel, as well as assets in Germany. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their views on legalization in Europe and their business model.
Analyst consensus forecast for stock prices by market segment - Narco farm
IM Cannabis (IMCC) is a Canadian company attempting to build an international cannabis brand by operating in Canada, Germany, and Israel. This chart reflects analysts' general expectations for the entire "drug farm" sector. It shows whether experts believe in global legalization or consider the market too chaotic.
Analysts' consensus forecast for the overall market share price
IM Cannabis (IMCC) is an international player in the cannabis market. They operate in Israel and Germany, attempting to build a brand in two of the most challenging regulatory markets. This chart shows the overall risk appetite, reflecting investors' willingness to invest in the unprofitable but potentially growing legal cannabis sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index IM Cannabis Corp.
IM Cannabis (IMCC) is a global cannabis player. They began as a medical cannabis pioneer in Israel and are now trying to build a transatlantic business, also operating in Germany and Canada. This chart is a summary indicator of their global strategy. It reflects their ability to survive the (unprofitable) Canadian legalization war and their dependence on (slow) legalization in Europe.
AKIMA Market Segment Index - Narco farm
IM Cannabis (IMCC) is an international player in the cannabis market. Unlike many, they focus on key medical markets such as Israel and Germany, as well as the Canadian market. This chart shows the average index for the segment, helping investors assess how this medical strategy stacks up against the average in the volatile cannabis sector.
The AKIM Index for the overall market
IM Cannabis is an international operator of medical and recreational cannabis (Israel, Germany, Canada). This chart, which reflects the market average, provides a macro backdrop. It helps assess how IMCC, which operates in regulated markets, compares to the overall economic situation.